Objective: To investigate the distribution characteristics of previous infection of human parvovirus B19(HPV B19) among blood donors in Xi 'an, and to provide data support and theoretical basis for formulating individualized and precise blood screening strategies. Methods: A total of 970 qualified blood samples tested at Shaanxi Blood Center from August to September 2024 were randomly selected. The levels of HPV B19 IgG antibodies in the serum were detected by enzyme-linked immunosorbent assay (ELISA). The distribution characteristics of the samples were analyzed from the perspectives of age, gender, education level, occupation, blood type and region. Results: The positive rate of HPV B19 IgG antibodies among blood donors in Xi 'an was 25.26%(245/970), which increased gradually with age (P<0.05). There was no significant difference in the positive rate of HPV B19 IgG antibodies among blood donors of different genders, education levels, occupations, or blood types (P>0.05). Univariate logistic regression analysis showed that past HPV B19 infection was only related to age (P<0.05). The distribution of positive blood samples in 13 districts and counties of Xi 'an was counted based on the blood collection sites. The results showed that there was no significant global spatial autocorrelation in the distribution of positive samples. Among them, the Weiyang District and Beilin District exhibited a "high-high" cluster (P<0.05), while Chang'an District exhibited a "low-high" cluster (P<0.01). Conclusion: A certain proportion of blood donors in Xi'an showed past infection with HPV B19, which was only correlated with age and demonstrated an upward trend. It is recommended to continue expanding the screening scope and incorporate screening for this virus in blood transfusion processes involving susceptible populations.

Objective: To reveal the molecular biological mechanism of a rare Dc-variant individual using PacBio third-generation sequencing technology. Methods: ABO and Rh blood type identification, DAT, unexpected antibody screening and D antigen enhancement test were conducted by serological testing. The absorption-elution test was used to detect the e antigen. RHCE gene typing was performed by PCR-SSP, and the 1-10 exons of RHCE were sequenced by Sanger sequencing. The full-length sequences of RHCE, RHD and RHAG were detected by PacBio third-generation sequencing technology. Results: Serological findings: Blood type O, Dc-phenotype, DAT negative, unexpected antibody screening negative; enhanced D antigen expression; no detection of e antigen in the absorption-elution test. PCR-SSP genotyping indicated the presence of only the RHCE c allele. Sanger sequencing results: Exons 5-9 of RHCE were deleted, exon 1 had a heterozygous mutation at c. 48G/C, and exon 2 had five heterozygous mutations at c. 150C/T, c. 178C/A, c. 201A/G, c. 203A/G and c. 307C/T. Third-generation sequencing results: RHCE genotype was RHCE 02N. 08/RHCE-D(5-9)-CE; RHD genotype was RHD 01/RHD 01; RHAG genotype was RHAG 01/RHAG 01 (c. 808G>A and c. 861G>A). Conclusion: This Dc-individual carries the allele RHCE 02N. 08 and the novel allele RHCE-D(5-9)-CE. The findings of this study provide data support and a theoretical basis for elucidating the molecular mechanisms underlying RhCE deficiency phenotypes.

Objective To investigate the association of liver radiodensity with the degree and progression of liver fibrosis in patients with chronic hepatitis B(CHB).Methods A retrospective cohort study was conducted among 114 CHB patients who were hospitalized in The First Hospital of Lanzhou University from January to December 2019,and related clinical data were collected,including laboratory tests and abdominal CT.The metabolic characteristics of the patients were assessed,and liver radiodensity was measured.An analysis of variance was used for comparison of normally distributed continuous data between three groups,and the Kruskal-Wallis H rank sum test was used for comparison of continuous data with skewed distribution between three groups;the chi-square test or the Fisher's exact test was used for comparison of categorical data between three groups.A logistic regression analysis was used to investigate the influencing factors for the degree of liver fibrosis,and the Cox proportional-hazards regression model analysis was used to investigate the influencing factors for the progression of liver fibrosis in CHB.Results Among the 114 patients enrolled,43(37.72％)had no liver cirrhosis,30(26.32％)were suspected of liver cirrhosis,and 41(35.96％)had liver cirrhosis,with a median follow-up time of 538.5(322.75-1 031.50)days.Liver radiodensity on plain scan(odds ratio[OR]=0.81,95％confidence interval[CI]:0.68-0.97,P=0.025),liver radiodensity on contrast-enhanced scan(OR=0.95,95％CI:0.90-0.99,P=0.037),and liver volume(OR=0.99,95％CI:0.98-0.99,P<0.001)were independent influencing factors for the degree of liver fibrosis.The univariate Cox regression analysis showed that the low level of HDL(hazard ratio=2.81,95％CI:1.04-7.54,P=0.041)was associated with the progression of liver fibrosis in CHB patients,and the degree of liver fibrosis,liver volume,and liver radiodensity showed no significant association with the progression of liver fibrosis(all P>0.05).Conclusion In CHB patients,liver radiodensity is an independent influencing factor for the degree of liver fibrosis,and low HDL has a marked influence on the progression of liver fibrosis.

Lung cancer is one of the malignant tumours with the highest morbidity and mortality rates worldwide today, posing a major threat to human health. Accurate diagnosis and standardised treatment play a crucial role in improving the survival rate of lung cancer patients. In recent years, the rapid rise of artificial intelligence (AI) has brought about significant changes in the medical field, providing a new diagnostic and treatment model for lung cancer, and making a series of breakthroughs in lung cancer diagnostic imaging, pathological diagnosis, surgical oncology, radiotherapy, and drug development and treatment. This article introduces the current status of AI application in the field of lung cancer diagnosis and treatment, and extensively discusses the current challenges and future prospects, hoping to provide references and suggestions for future clinical practice.

Objective:To establish 30-day of age transcutaneous bilirubin (TcB) reference curves for healthy neonates, and to investigate regional variations in bilirubin dynamics.Methods:A multicenter retrospective cohort study was conducted. A total of 220 950 healthy neonates born at a gestational age of 35-<42 weeks, with a birth weight ≥2 000 g, who did not receive phototherapy within 60 h after birth were recruited. All of them underwent remote TcB monitoring using the Bilibaby remote jaundice monitoring system between August 1 st, 2020 and December 31 st, 2024 in 426 hospitals. TcB data were collected within the period from birth to 30-day of age. The P40, P75, and P95 of TcB values were calculated, and dynamic TcB curves for 30-day of age were constructed. Patterns of bilirubin change, rates of change, and transition outcomes were described. Regional comparisons between South and North were conducted using linear mixed-effects models for TcB trajectories and Pearson′s chi-square test for outcome differences. Results:A total of 220 950 neonates were included, of whom 101 711 (46.03%) were female. Gestational age at birth was (38.75±1.12) weeks, and birth weight was (3 272±417) g. TcB levels increased rapidly within 3-day of age, peaked at 4-6-day of age, with peak values at P40, P75, and P95 of 200.6, 239.7 and 275.4 μmol/L (11.8, 14.1 and 16.2 mg/dl), respectively. TcB levels gradually declined thereafter and stabilized after 13-day of age, with values at P40, P75, and P95 fluctuating between 147.9-159.8, 190.4-200.6, and 231.2-239.7 μmol/L (8.7-9.4, 11.2-11.8, 13.6-14.1 mg/dl), respectively. Notably, among neonates categorized as low-or low-intermediate-risk within 3-day of age, 6 700 (12.76%) progressed to intermediate-high or high risk between 4 and 30 days of age. Before 13-day of age, TcB levels in the southern regions were consistently higher than those in the northern regions ( P=0.039); from 14 to 30 days of age, the overall TcB levels had no statistically difference, but the temporal changes in TcB still showed regional differences (degrees of freedom=3, all interaction P<0.05). Among neonates classified as low-or low-intermediate risk within 3-day of age, 25 326 were from southern regions, of whom 4 254 (16.80%) progressed to intermediate-high or high risk between 4 and 30 days of age. In northern regions, 27 193 neonates were classified as low-or low-intermediate risk within 3-day of age, among whom 2 446 (8.99%) progressed to intermediate-high or high risk. The risk progression between the 2 regions had statistically difference ( χ2=716.49, P<0.001). Conclusions:A TcB percentile curve for neonates within 30-day of age was established, revealing that both the overall TcB level and its temporal trend were higher in southern than in northern newborns. These findings provide baseline data to support continuous management of neonatal jaundice.

Objective To study the effects of ethanol extract of the root of anacyclus pyrethrum(EEAP)on blood glucose and gut microbiota in mice induced by high-fat diet.Methods Forty-eight male C57BL/6N mice were randomly allocated into groups using a random number table:control group,model group,low-,medium-,and high-dose EEAP groups,as well as a metformin group,with each group consisting of 8mice.Mice in the low,medium,and high dose EEAP groups were administered EEAP at 100,200 and 400mg/kg,respectively.The metformin group was given metformin at 280mg/kg.Both the control and model groups were given an equivalent a-mount of distilled water.Gavage was performed once daily for 12 consecutive weeks.Except the control group mice were fed normal diet,the other groups were fed high-fat diet.Fasting and random blood glucose were detected by blood glucose test strips.The levels of in-flammatory factors in mice were detected by enzyme-linked immunosorbent assay kit.Gut microbiota was detected by 16S rDNA real-time quantitative polymerase chain reaction.Results At 12th weeks,compared with the model group,the body mass of mice in low-dose,medium-dose and high-dose EEAP groups and metformin group were decreased significantly.Compared with the model group,the fasting blood glucose and random blood glucose in high-dose EEAP group and metformin group were significantly decreased.Com-pared with the model group,the abundations of Akkermansia muciniphila and Faecalibacterium prausnitzii in the intestinal tracts of mice in medium-dose and high-dose EEAP groups and metformin group were significantly increased,while the abundations of desulfovibrio were significantly decreased.Conclusion EEAP can improve dysglycemia induced by high-fat diet in mice,and its mechanism may be related to regulating gut microbiota and inhibiting inflammatory reaction.

Post-stroke cognitive impairment(PSCI)is a major cause of disability and mortality follow-ing stroke,significantly affecting patients' quality of life and prognosis.In recent years,research on the rela-tionship between oral microbiota and cognitive function has emerged as a prominent topic,however,studies fo-cusing specifically on PSCI patients are limited,and the association between oral microbiota dysbiosis and PS-CI remains underexplored.This review summarized the current studies regarding oral microbiota and PSCI,the potential pathways,and interventions targeting oral microbiota.It aims to provide new perspectives for fu-ture research into the underlying mechanisms,disease prevention,and therapeutic strategies for PSCI.

Lung cancer is one of the malignant tumours with the highest morbidity and mortality rates worldwide today, posing a major threat to human health. Accurate diagnosis and standardised treatment play a crucial role in improving the survival rate of lung cancer patients. In recent years, the rapid rise of artificial intelligence (AI) has brought about significant changes in the medical field, providing a new diagnostic and treatment model for lung cancer, and making a series of breakthroughs in lung cancer diagnostic imaging, pathological diagnosis, surgical oncology, radiotherapy, and drug development and treatment. This article introduces the current status of AI application in the field of lung cancer diagnosis and treatment, and extensively discusses the current challenges and future prospects, hoping to provide references and suggestions for future clinical practice.

Objective To investigate the association of liver radiodensity with the degree and progression of liver fibrosis in patients with chronic hepatitis B(CHB).Methods A retrospective cohort study was conducted among 114 CHB patients who were hospitalized in The First Hospital of Lanzhou University from January to December 2019,and related clinical data were collected,including laboratory tests and abdominal CT.The metabolic characteristics of the patients were assessed,and liver radiodensity was measured.An analysis of variance was used for comparison of normally distributed continuous data between three groups,and the Kruskal-Wallis H rank sum test was used for comparison of continuous data with skewed distribution between three groups;the chi-square test or the Fisher's exact test was used for comparison of categorical data between three groups.A logistic regression analysis was used to investigate the influencing factors for the degree of liver fibrosis,and the Cox proportional-hazards regression model analysis was used to investigate the influencing factors for the progression of liver fibrosis in CHB.Results Among the 114 patients enrolled,43(37.72％)had no liver cirrhosis,30(26.32％)were suspected of liver cirrhosis,and 41(35.96％)had liver cirrhosis,with a median follow-up time of 538.5(322.75-1 031.50)days.Liver radiodensity on plain scan(odds ratio[OR]=0.81,95％confidence interval[CI]:0.68-0.97,P=0.025),liver radiodensity on contrast-enhanced scan(OR=0.95,95％CI:0.90-0.99,P=0.037),and liver volume(OR=0.99,95％CI:0.98-0.99,P<0.001)were independent influencing factors for the degree of liver fibrosis.The univariate Cox regression analysis showed that the low level of HDL(hazard ratio=2.81,95％CI:1.04-7.54,P=0.041)was associated with the progression of liver fibrosis in CHB patients,and the degree of liver fibrosis,liver volume,and liver radiodensity showed no significant association with the progression of liver fibrosis(all P>0.05).Conclusion In CHB patients,liver radiodensity is an independent influencing factor for the degree of liver fibrosis,and low HDL has a marked influence on the progression of liver fibrosis.

Objective To study the effects of ethanol extract of the root of anacyclus pyrethrum(EEAP)on blood glucose and gut microbiota in mice induced by high-fat diet.Methods Forty-eight male C57BL/6N mice were randomly allocated into groups using a random number table:control group,model group,low-,medium-,and high-dose EEAP groups,as well as a metformin group,with each group consisting of 8mice.Mice in the low,medium,and high dose EEAP groups were administered EEAP at 100,200 and 400mg/kg,respectively.The metformin group was given metformin at 280mg/kg.Both the control and model groups were given an equivalent a-mount of distilled water.Gavage was performed once daily for 12 consecutive weeks.Except the control group mice were fed normal diet,the other groups were fed high-fat diet.Fasting and random blood glucose were detected by blood glucose test strips.The levels of in-flammatory factors in mice were detected by enzyme-linked immunosorbent assay kit.Gut microbiota was detected by 16S rDNA real-time quantitative polymerase chain reaction.Results At 12th weeks,compared with the model group,the body mass of mice in low-dose,medium-dose and high-dose EEAP groups and metformin group were decreased significantly.Compared with the model group,the fasting blood glucose and random blood glucose in high-dose EEAP group and metformin group were significantly decreased.Com-pared with the model group,the abundations of Akkermansia muciniphila and Faecalibacterium prausnitzii in the intestinal tracts of mice in medium-dose and high-dose EEAP groups and metformin group were significantly increased,while the abundations of desulfovibrio were significantly decreased.Conclusion EEAP can improve dysglycemia induced by high-fat diet in mice,and its mechanism may be related to regulating gut microbiota and inhibiting inflammatory reaction.